Fancl Corp
TSE:4921
Fancl Corp
Cash & Cash Equivalents
Fancl Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F
|
Fancl Corp
TSE:4921
|
Cash & Cash Equivalents
¥42.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
18%
|
CAGR 10-Years
8%
|
Shiseido Co Ltd
TSE:4911
|
Cash & Cash Equivalents
¥90.4B
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Cash & Cash Equivalents
¥89.2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Cash & Cash Equivalents
¥47.2B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
3%
|
|
Kao Corp
TSE:4452
|
Cash & Cash Equivalents
¥245.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Cash & Cash Equivalents
¥62.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
2%
|
See Also
What is Fancl Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
42.1B
JPY
Based on the financial report for Mar 31, 2024, Fancl Corp's Cash & Cash Equivalents amounts to 42.1B JPY.
What is Fancl Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
8%
Over the last year, the Cash & Cash Equivalents growth was 14%. The average annual Cash & Cash Equivalents growth rates for Fancl Corp have been 18% over the past three years , 18% over the past five years , and 8% over the past ten years .